This included survival of both AML blasts, identified as CD34+ and/or CD117+ cells, and of the remaining more mature CD34-/CD117- cells in the sample (Fig 2A and 2B) (See S1 Fig for flow cytometry gating strategy). This evidence concerns the gene KIT and acute myeloid leukemia.